CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • United States
    Entity • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Trade Omnicell - OMCL CFD

    74.70
    1.55%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.20
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.025457%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		0.003235%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 20%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Omnicell Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 73.54
    Open* 74.42
    1-Year Change* -34.1%
    Day's Range* 74.23 - 74.95
    52 wk Range 46.11-125.17
    Average Volume (10 days) 373.80K
    Average Volume (3 months) 9.52M
    Market Cap 3.32B
    P/E Ratio -100.00K
    Shares Outstanding 45.08M
    Revenue 1.27B
    EPS -0.41
    Dividend (Yield %) N/A
    Beta 0.90
    Next Earnings Date Aug 2, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    May 26, 2023 73.54 1.13 1.56% 72.41 74.06 71.33
    May 25, 2023 72.61 0.07 0.10% 72.54 73.08 71.33
    May 24, 2023 73.00 1.73 2.43% 71.27 73.62 70.21
    May 23, 2023 71.95 -0.28 -0.39% 72.23 76.03 71.10
    May 22, 2023 74.59 2.63 3.65% 71.96 74.92 71.96
    May 19, 2023 73.26 0.01 0.01% 73.25 74.73 72.27
    May 18, 2023 73.19 1.98 2.78% 71.21 73.60 71.00
    May 17, 2023 72.15 2.20 3.15% 69.95 72.56 69.44
    May 16, 2023 70.16 2.25 3.31% 67.91 70.72 67.90
    May 15, 2023 69.98 -0.97 -1.37% 70.95 71.19 69.62
    May 12, 2023 70.90 3.14 4.63% 67.76 71.17 67.76
    May 11, 2023 67.80 2.83 4.36% 64.97 67.85 64.97
    May 10, 2023 66.96 1.22 1.86% 65.74 67.52 65.60
    May 9, 2023 65.40 0.77 1.19% 64.63 65.58 63.83
    May 8, 2023 64.96 -0.41 -0.63% 65.37 65.37 64.22
    May 5, 2023 65.77 0.56 0.86% 65.21 66.21 64.79
    May 4, 2023 65.18 -1.28 -1.93% 66.46 66.87 64.66
    May 3, 2023 66.89 4.93 7.96% 61.96 67.81 61.61
    May 2, 2023 58.35 -3.08 -5.01% 61.43 61.69 58.27
    May 1, 2023 61.39 1.20 1.99% 60.19 61.96 59.96

    Omnicell Events

    Time (UTC) Country Event
    Wednesday, August 2, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q2 2023 Omnicell Inc Earnings Release
    Q2 2023 Omnicell Inc Earnings Release

    Forecast

    -

    Previous

    -
    Tuesday, October 31, 2023

    Time (UTC)

    12:30

    Country

    US

    Event

    Q3 2023 Omnicell Inc Earnings Release
    Q3 2023 Omnicell Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1295.95 1132.02 892.208 897.027 787.309
    Revenue 1295.95 1132.02 892.208 897.027 787.309
    Cost of Revenue, Total 698.942 576.976 476.352 460.115 414.979
    Gross Profit 597.005 555.042 415.856 436.912 372.33
    Total Operating Expense 1298.27 1042.51 856.682 818.675 742.917
    Selling/General/Admin. Expenses, Total 475.171 387.904 303.924 289.916 263.095
    Research & Development 101.354 75.611 66.445 68.644 64.843
    Operating Income -2.323 89.507 35.526 78.352 44.392
    Interest Income (Expense), Net Non-Operating -0.13 -23.5 -6.177 -4.419 -8.776
    Net Income Before Taxes -2.453 66.007 29.349 73.933 35.616
    Net Income After Taxes 5.648 77.849 32.194 61.338 37.729
    Net Income Before Extra. Items 5.648 77.849 32.194 61.338 37.729
    Total Extraordinary Items 0 0
    Net Income 5.648 77.849 32.194 61.338 37.729
    Income Available to Common Excl. Extra. Items 5.648 77.849 32.194 61.338 37.729
    Income Available to Common Incl. Extra. Items 5.648 77.849 32.194 61.338 37.729
    Diluted Net Income 5.648 77.849 32.194 61.338 37.729
    Diluted Weighted Average Shares 45.891 47.943 43.743 42.943 40.559
    Diluted EPS Excluding Extraordinary Items 0.12307 1.62378 0.73598 1.42836 0.93023
    Diluted Normalized EPS 0.44606 1.79624 0.884 1.42836 0.99914
    Unusual Expense (Income) 22.803 2.02 9.961
    Dilution Adjustment 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 290.629 297.674 348.059 331.386 318.828
    Revenue 290.629 297.674 348.059 331.386 318.828
    Cost of Revenue, Total 165.456 168.503 188.52 173.294 168.625
    Gross Profit 125.173 129.171 159.539 158.092 150.203
    Total Operating Expense 313.592 336.031 329.594 318.901 313.744
    Selling/General/Admin. Expenses, Total 120.429 123.382 114.381 119.252 118.156
    Research & Development 22.393 26.664 24.899 26.355 23.436
    Unusual Expense (Income) 5.314 17.482 1.794 0 3.527
    Operating Income -22.963 -38.357 18.465 12.485 5.084
    Interest Income (Expense), Net Non-Operating 1.781 2.843 -1.148 -1.711 -0.114
    Net Income Before Taxes -21.182 -35.514 17.317 10.774 4.97
    Net Income After Taxes -15 -28.408 16.774 9.069 8.213
    Net Income Before Extra. Items -15 -28.408 16.774 9.069 8.213
    Net Income -15 -28.408 16.774 9.069 8.213
    Income Available to Common Excl. Extra. Items -15 -28.408 16.774 9.069 8.213
    Income Available to Common Incl. Extra. Items -15 -28.408 16.774 9.069 8.213
    Diluted Net Income -15 -28.408 16.774 9.069 8.213
    Diluted Weighted Average Shares 44.887 44.68 45.819 46.26 47.918
    Diluted EPS Excluding Extraordinary Items -0.33417 -0.63581 0.36609 0.19604 0.1714
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.25722 -0.38148 0.40402 0.19604 0.21924
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 881.812 780.702 829.414 483.238 397.134
    Cash and Short Term Investments 341.848 359.716 496.174 127.21 67.192
    Cash
    Cash & Equivalents 330.362 349.051 485.928 127.21 67.192
    Total Receivables, Net 299.469 240.894 190.117 218.362 196.238
    Accounts Receivable - Trade, Net 299.469 240.894 190.117 218.362 196.238
    Total Inventory 147.549 119.924 96.298 108.011 100.868
    Prepaid Expenses 28.772 29.155 26.122 14.478 20.7
    Other Current Assets, Total 64.174 31.013 20.703 15.177 12.136
    Total Assets 2210.76 2142.5 1824.5 1240.81 1081.24
    Property/Plant/Equipment, Total - Net 132.013 119.69 114.187 110.376 51.5
    Property/Plant/Equipment, Total - Gross 258.657 241.637 220.488 226.091 152.289
    Accumulated Depreciation, Total -126.644 -121.947 -106.301 -115.715 -100.789
    Goodwill, Net 734.274 738.9 499.309 336.539 335.887
    Intangibles, Net 323.666 374.611 262.238 209.937 200.505
    Long Term Investments 32.924 18.391 22.156 19.75 17.082
    Other Long Term Assets, Total 91.325 92.118 79.995 68.71 62.653
    Total Current Liabilities 428.446 876.158 276.423 236.996 204.58
    Accounts Payable 63.389 71.513 40.309 46.38 38.038
    Accrued Expenses 224.912 192.335 125.56 91.972 69.829
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 488.152 0
    Other Current Liabilities, Total 140.145 124.158 110.554 98.644 96.713
    Total Liabilities 1080.62 995.807 857.001 395.556 401.625
    Total Long Term Debt 566.571 0 467.201 50 135.417
    Long Term Debt 566.571 0 467.201 50 135.417
    Deferred Income Tax 2.095 51.705 39.633 39.09 41.484
    Other Liabilities, Total 83.509 67.944 73.744 69.47 20.144
    Total Equity 1130.14 1146.69 967.503 845.254 679.617
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.055 0.054 0.053 0.051 0.05
    Additional Paid-In Capital 1046.76 1024.58 920.359 780.931 678.041
    Retained Earnings (Accumulated Deficit) 390.728 368.571 290.722 258.792 197.454
    Treasury Stock - Common -290.319 -238.109 -238.109 -185.074 -185.074
    Other Equity, Total -17.087 -8.407 -5.522 -9.446 -10.854
    Total Liabilities & Shareholders’ Equity 2210.76 2142.5 1824.5 1240.81 1081.24
    Total Common Shares Outstanding 44.747 44.179 42.783 42.132 40.335
    Note Receivable - Long Term 14.744 18.084 17.205 12.26 16.481
    Short Term Investments 11.486 10.665 10.246
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 934.969 881.812 849.132 787.77 775.604
    Cash and Short Term Investments 351.466 341.848 278.988 257.265 276.111
    Cash & Equivalents 340.413 330.362 266.402 244.953 265.008
    Short Term Investments 11.053 11.486 12.586 12.312 11.103
    Total Receivables, Net 322.073 299.469 354.098 310.52 290.469
    Accounts Receivable - Trade, Net 322.073 299.469 354.098 310.52 290.469
    Total Inventory 141.156 147.549 147.096 150.461 137.056
    Prepaid Expenses 28.075 28.772 26.708 23.471 29.493
    Other Current Assets, Total 92.199 64.174 42.242 46.053 42.475
    Total Assets 2250.84 2210.76 2179.69 2131.46 2122.59
    Property/Plant/Equipment, Total - Net 126.601 132.013 132.489 128.074 120.266
    Property/Plant/Equipment, Total - Gross 258.735 258.657 255.308 257.982 246.491
    Accumulated Depreciation, Total -132.134 -126.644 -122.819 -129.908 -126.225
    Goodwill, Net 734.895 734.274 731.294 734.487 740.426
    Intangibles, Net 311.803 323.666 336.19 349.507 363.535
    Long Term Investments 32.744 32.924 33.807 29.209 19.051
    Note Receivable - Long Term 13.491 14.744 13.815 16.185 16.316
    Other Long Term Assets, Total 96.335 91.325 82.958 86.226 87.39
    Total Current Liabilities 453.968 428.446 376.681 373.514 951.012
    Accounts Payable 63.407 63.389 73.517 68.4 71.645
    Accrued Expenses 225.961 224.912 167.698 180.255 171.276
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 164.6 140.145 135.466 124.859 143.822
    Total Liabilities 1108.3 1080.62 1044.29 1038.82 1047.85
    Total Long Term Debt 567.342 566.571 565.803 565.035 0
    Long Term Debt 567.342 566.571 565.803 565.035
    Deferred Income Tax 1.558 2.095 16.14 23.906 28.173
    Other Liabilities, Total 85.429 83.509 85.666 76.366 68.662
    Total Equity 1142.54 1130.14 1135.4 1092.64 1074.74
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.055 0.055 0.055 0.055 0.054
    Additional Paid-In Capital 1072.69 1046.76 1030.67 997.911 982.675
    Retained Earnings (Accumulated Deficit) 375.728 390.728 419.136 402.362 393.293
    Treasury Stock - Common -290.319 -290.319 -290.319 -290.319 -290.319
    Other Equity, Total -15.608 -17.087 -24.142 -17.372 -10.962
    Total Liabilities & Shareholders’ Equity 2250.84 2210.76 2179.69 2131.46 2122.59
    Total Common Shares Outstanding 45.069 44.747 44.646 44.288 44.174
    Current Port. of LT Debt/Capital Leases 0 0 0 564.269
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 5.648 77.849 32.194 61.338 37.729
    Cash From Operating Activities 77.781 231.809 185.87 145.008 103.966
    Cash From Operating Activities 86.931 72.99 61.067 53.559 51.35
    Deferred Taxes -37.316 -3.272 -6.546 -1.339 -5.705
    Non-Cash Items 95.984 87.582 61.855 47.26 31.31
    Cash Taxes Paid 19.005 -1.733 10.343 7.761 3.489
    Cash Interest Paid 1.438 1.917 0.522 3.582 7.487
    Changes in Working Capital -73.466 -3.34 37.3 -15.81 -10.718
    Cash From Investing Activities -58.669 -412.498 -279.866 -61.664 -54.374
    Capital Expenditures -60.74 -58.335 -54.866 -61.664 -54.374
    Other Investing Cash Flow Items, Total 2.071 -354.163 -225 0 0
    Cash From Financing Activities -20.953 47.363 456.269 -23.479 -13.597
    Financing Cash Flow Items -8.925 -19.985 -5.296 -11.991 -6.775
    Issuance (Retirement) of Stock, Net -12.028 67.348 52.525 78.512 70.178
    Issuance (Retirement) of Debt, Net 0 0 409.04 -90 -77
    Foreign Exchange Effects -0.944 -0.974 0.437 0.153 -1.227
    Net Change in Cash -2.785 -134.3 362.71 60.018 34.768
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -15 5.648 34.056 17.282 8.213
    Cash From Operating Activities 12.77 77.781 -4.372 -25.547 -15.996
    Cash From Operating Activities 21.974 86.931 64.843 43.017 21.124
    Deferred Taxes -7.77 -37.316 -17.061 -9.506 -4.858
    Non-Cash Items 25.952 95.984 69.282 47.394 22.306
    Changes in Working Capital -12.386 -73.466 -155.492 -123.734 -62.781
    Cash From Investing Activities -13.64 -58.669 -41.417 -25.55 -18.733
    Capital Expenditures -13.64 -60.74 -43.509 -27.642 -15.341
    Cash From Financing Activities 3.862 -20.953 -24.515 -33.571 -32.119
    Financing Cash Flow Items -8.252 -8.925 -11.844 -2.484 1.14
    Issuance (Retirement) of Stock, Net 12.114 -12.028 -12.671 -31.087 -33.259
    Issuance (Retirement) of Debt, Net 0 0
    Foreign Exchange Effects 0.176 -0.944 -1.425 -2.123 -0.411
    Net Change in Cash 3.168 -2.785 -71.729 -86.791 -67.259
    Other Investing Cash Flow Items, Total 0 2.071 2.092 2.092 -3.392
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    BlackRock Institutional Trust Company, N.A. Investment Advisor 10.5396 4751336 -123085 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.8705 4449697 27525 2023-03-31 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 8.4627 3815052 537452 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.8134 1719109 42539 2023-03-31 LOW
    Credit Suisse Asset Management Investment Advisor/Hedge Fund 2.7787 1252676 -31674 2023-03-31 LOW
    ClearBridge Investments, LLC Investment Advisor/Hedge Fund 2.6499 1194602 21883 2023-03-31 LOW
    Conestoga Capital Advisors, LLC Investment Advisor 2.5099 1131485 -482855 2023-03-31 LOW
    ArrowMark Colorado Holdings, LLC Investment Advisor/Hedge Fund 2.2282 1004472 155509 2023-03-31 LOW
    Geneva Capital Management LLC Investment Advisor 2.2262 1003571 40802 2023-03-31 LOW
    Champlain Investment Partners, LLC Investment Advisor 2.1827 983995 281305 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.9542 880970 43600 2023-03-31 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.6487 743234 -15189 2023-03-31 LOW
    Macquarie Investment Management Investment Advisor 1.6374 738128 16914 2023-03-31 LOW
    Point72 Asset Management, L.P. Hedge Fund 1.3751 619900 619900 2023-03-31 LOW
    Managed Account Advisors LLC Investment Advisor 1.2191 549560 129014 2023-03-31 LOW
    Scout Investments, Inc. Investment Advisor 1.2024 542031 51138 2023-03-31 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 1.1317 510167 7612 2023-03-31 LOW
    Mirae Asset Global Investments (USA) LLC Investment Advisor 1.123 506260 117313 2023-03-31 LOW
    RBC Global Asset Management (U.S.) Inc. Investment Advisor/Hedge Fund 1.1012 496428 64312 2023-03-31 LOW
    Trillium Asset Management, LLC Investment Advisor 1.0935 492954 41701 2023-03-31 LOW

    Why choose Capital.com? Our numbers speak for themselves.

    Capital.com Group

    530K+

    Traders

    87K+

    Active clients monthly

    $46M+

    Monthly investing volume

    $31M+

    Withdrawn each month

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Profit/Loss

    Omnicell Company profile

    About Omnicell, Inc.

    Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. Its point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility’s in-house information management systems. Its Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Omnicell, Inc. revenues increased 27% to $1.13B. Net income increased from $32.2M to $77.8M. Revenues reflect Connected devices, software licenses, and other segment increase of 32% to $739.1M, SaaS, subscription software, and technology-enabled services segment increase from $53.8M to $112.5M, United States segment increase of 28% to $1.02B, Rest of the World segment increase of 18% to $111.2M.

    Equity composition

    Common Stock $.001 Par, 12/10, 100M auth., 37,148,706 issd. 4,121,123 shs. in Treas. @$65.1M. Insiders own 2.25%. Initial Public Offering: 8/07/01, 6Mshares @ $7 by U.S. Bancorp Piper Jaffray. 7/01 1-for-1.6 stock split. *NOTE: 8/01, the Company changed it's name from Omnicell.com.

    Industry: Medical Software & Technology Services

    4220 North Freeway
    FORT WORTH
    TEXAS 76137
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Benjamin Franklin’s face on a $100 bill

    USD forecast: DXY slides in risk-off market sentiment

    The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.

    16:10, 24 May 2023
    Oil wells pictured in an oil field, silhouetted against clouds

    Oil price forecast: Will WTI and Brent regain momentum in 2023?

    Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.

    11:38, 22 May 2023
    businessman using a mobile phone to check stock market data

    Weekly Roundup: Tech stocks lead the way

    US stocks push higher as risk appetite surges despite the uncertainty

    13:39, 19 May 2023
    Japanese yen currency

    USD/JPY continues to build higher towards 138

    USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher

    11:50, 17 May 2023
    Gold bars on a black background with a diagram

    Gold price predictions for next 5 years: Will gold continue rising?

    The yellow metal reached near record-highs, yet will it maintain the momentum and for how long?

    07:50, 17 May 2023
    Close-up of a $20 banknote and gold bullion

    Gold price forecast: Will gold surpass record highs?

    The US debt ceiling concerns and the banking crisis have been favourable for gold, yet is there more upside potential?

    12:52, 16 May 2023

    Top AI stocks: What companies are leading the AI revolution?

    Unravel key AI market leaders and their latest products, key AI industry trends and forecasts.

    14:55, 15 May 2023

    People also watch

    Oil - Crude

    69.71 Price
    -4.640% 1D Chg, %
    Long position overnight fee -0.0146%
    Short position overnight fee -0.0073%
    Overnight fee time 21:00 (UTC)
    Spread 0.03

    Gold

    1,962.15 Price
    +1.010% 1D Chg, %
    Long position overnight fee -0.0183%
    Short position overnight fee 0.0101%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    US100

    14,419.70 Price
    +0.260% 1D Chg, %
    Long position overnight fee -0.0255%
    Short position overnight fee 0.0032%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    XRP/USD

    0.51 Price
    +3.030% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.00534

    Still looking for a broker you can trust?

    Join the 530.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading